Key result
Low socioeconomic status was not independently associated with 30-day mortality or 1-year all-cause mortality in patients with STEMI managed by an emergency network.
Why the study?
Despite the spread of STEMI emergency intervention networks, healthcare access inequalities still negatively impact cardiovascular prognosis, prompting evaluation of the effect of socioeconomic status on mortality and complications.
Does low socioeconomic status increase 30-day mortality, 30-day cardiovascular complications, or 1-year mortality in patients with STEMI managed by an emergency intervention network?
Cohort (n=3,322)
Yes
Does low socioeconomic status increase 30-day mortality, 30-day cardiovascular complications, or 1-year mortality in patients with STEMI managed by an emergency intervention network?
In a contemporary STEMI network, low socioeconomic status was associated with worse baseline clinical profiles and longer revascularization delays, but not with worse 30-day or 1-year mortality, suggesting a robust healthcare system may mitigate socioeconomic disparities.
Answers are grounded in this paper and cite their sources.
Suggests robust STEMI networks may attenuate SES mortality gaps; hypothesis-generating for system-level interventions.
Background: Despite the spread of ST-elevation myocardial infarction (STEMI) emergency intervention networks, inequalities in healthcare access still have a negative impact on cardiovascular prognosis. The Family Income Ratio of Barcelona (FIRB) is a socioeconomic status (SES) indicator that is annually calculated. Our aim was to evaluate whether SES had an effect on mortality and complications in patients managed by the "Codi IAM" network in Barcelona. Methods: This is a cohort study with 3,322 consecutive patients with STEMI treated in Barcelona from 2010 to 2016. Collected data include treatment delays, clinical and risk factor characteristics, and SES. The patients were assigned to three SES groups according to FIRB score. A logistic regression analysis was conducted to estimate the adjusted effect of SES on 30-day mortality, 30-day composite cardiovascular end point, and 1-year mortality. Low SES was not independently associated with 30-day mortality (OR: 0.95;9 5% CI: 0.7-1.3), 30-day cardiovascular composite end point (OR: 1.03; 95% CI: 0.84-1.26), or 1-year all-cause mortality (HR: 1.09; 95% CI: 0.76-1.56). Conclusion: Although the low-SES patients with STEMI in Barcelona city were younger, had worse clinical profiles, and had longer revascularization delays, their 30-day and 1-year outcomes were comparable to those of the higher-SES patients.
No takes yet. Share an insight, caveat, or question.
Tizón‐Marcos et al. (2022) conducted a cohort in ST-elevation myocardial infarction (STEMI) (n=3,322). Low socioeconomic status vs. Mid and high socioeconomic status was evaluated on 30-day mortality (OR 0.95, 95% CI 0.7-1.3). Low socioeconomic status was not independently associated with 30-day mortality or 1-year all-cause mortality in patients with STEMI managed by an emergency network.
Synapse has enriched 10 related papers. Consider them for comparative context: